Posts filed under: Vascular

US Peripheral Vascular Device Market: Shifting Demographics, Technological Innovation Fueling Growth

Growth of the United States’ elderly population has driven a steady increase in the number of patients requiring treatment for peripheral vascular lesions. The subsequent rise in procedural volume has applied upward pressure on the value of the U.S. market...
Continue Reading →

Vascular Closure Devices to Drive U.S. Peripheral Vascular Device Market

In 2009, over 650,000 vascular closure devices (VCDs) were sold in the U.S. for use in peripheral vascular procedures, which accounted for approximately 20% of vascular closure devices used in all applications....
Continue Reading →

U.S. Peripheral Vascular Market to Exceed $5.3 Billion by 2016

Growth in the U.S. peripheral vascular device market, which was valued at $2.8 billion in 2009, will be primarily driven by increased detection and treatment of abdominal aortic aneurysms (AAAs) and peripheral arterial disease (PAD)....
Continue Reading →

Reimbursement Changes to Drive Vascular Access Market

Recent changes in Medicare and Medicaid reimbursement have significantly affected the U.S. market for vascular access devices....
Continue Reading →

Thank you!

Report Type Info

Single License: A single license is for use by a single individual only. Usage rights may not be transferred, sold or distributed by any means.

Site License: A site license allows sharing of the reports between various users within the purchasing company’s designated business address within this agreement.

Corporate License: A corporate license is for the use of one corporation. A corporation is defined as any business entity incorporated under a single name. Separate corporations operating under the same parent company are not included in this license.

Executive Summary: An in-depth summary of the reports associated with the related MedSuite product.



Sign Up

or Login